• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

TK8N:GR

1.043 EUR 0.088 9.21%

As of 09:32:38 ET on 07/11/2014.

Snapshot for Telik Inc (TK8N)

Open: 1.053 Day's Range: 1.043 - 1.053 Volume: 0
Previous Close: 0.955 52wk Range: 0.835 - 1.448 1-Yr Rtn: -7.86%

Stock Chart for TK8N

No chart data available.
  • TK8N:GR 1.043
  • 1D
  • 1M
  • 1Y
0.955
Interactive TK8N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TK8N

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 14.53
Shares Outstanding (M) 13.93
30 Day Average Volume 133
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TK8N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TK8N

Telik, Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs to treat serious diseases. The Company's most advanced product development programs are for the treatment of cancer and diabetes.

J David HansenPresident/CEOGregory P HansonChief Financial Officer
Philip O LivingstonChief Science OfficerWolfgang W ScholzVP:Antibody Discovery
More Company Profile & Key Executives for TK8N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil